GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Agentix Corp (OTCPK:AGTX) » Definitions » Cyclically Adjusted PB Ratio

Agentix (Agentix) Cyclically Adjusted PB Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Agentix Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Agentix Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Agentix's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agentix Cyclically Adjusted PB Ratio Chart

Agentix Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only - - - - -

Agentix Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Agentix's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Agentix's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agentix's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Agentix's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Agentix's Cyclically Adjusted PB Ratio falls into.



Agentix Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Agentix's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Agentix's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.071/129.4194*129.4194
=-0.071

Current CPI (Dec. 2023) = 129.4194.

Agentix Quarterly Data

Book Value per Share CPI Adj_Book
201402 0.000 99.057 0.000
201405 0.000 100.373 0.000
201408 0.198 100.352 0.255
201411 0.105 99.635 0.136
201502 0.039 99.032 0.051
201505 0.058 100.333 0.075
201508 0.017 100.548 0.022
201511 0.017 100.135 0.022
201602 0.017 100.040 0.022
201605 0.002 101.355 0.003
201608 -0.003 101.617 -0.004
201611 -0.246 101.829 -0.313
201702 -0.464 102.779 -0.584
201705 -0.063 103.256 -0.079
201708 -0.108 103.587 -0.135
201711 -0.130 104.072 -0.162
201802 -0.176 105.052 -0.217
201805 -0.020 106.148 -0.024
201808 -0.026 106.383 -0.032
201811 -0.038 106.338 -0.046
201902 -0.047 106.649 -0.057
201905 -0.053 108.048 -0.063
201908 -0.061 108.245 -0.073
201911 -0.007 108.519 -0.008
202002 -0.011 109.139 -0.013
202005 -0.012 108.175 -0.014
202008 0.006 109.662 0.007
202011 0.000 109.793 0.000
202102 -0.007 110.968 -0.008
202105 -0.009 113.576 -0.010
202108 -0.016 115.421 -0.018
202111 -0.021 117.269 -0.023
202202 -0.025 119.703 -0.027
202206 -0.032 125.017 -0.033
202209 -0.041 125.227 -0.042
202212 -0.048 125.222 -0.050
202303 -0.056 127.348 -0.057
202306 -0.066 128.729 -0.066
202309 -0.070 129.860 -0.070
202312 -0.071 129.419 -0.071

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Agentix  (OTCPK:AGTX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Agentix Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Agentix's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Agentix (Agentix) Business Description

Industry
Traded in Other Exchanges
N/A
Address
32932 Pacific Coast Highway, Suite 14-254, Dana Point, CA, USA, 92629
Agentix Corp is a biotechnology company. It is engaged in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease, and ischemic reperfusion injury. Its principal business objective is to develop both science-driven synthetic and natural cannabinoid therapeutics that address unmet medical needs and continue to drive innovations in the endocannabinoid space.
Executives
Thomas E Puzzo 10 percent owner 4216 NE 70TH STREET, SEATTLE WA 98115
Michael Winterhalter director, 10 percent owner, officer: President, CEO, CFO, Treasurer 32932 PACIFIC COAST HIGHWAY, #14-254, DANA POINT CA 92629
Grays Peak Ventures Llc 10 percent owner 320 PARK AVE, NEW YORK NY 10022
Scott B Stevens director, officer: President and Director 9701 WILSHIRE BLVD., SUITE 1000, BEVERLY HILLS CA 90212
Robert K Whalen director, officer: Secretary and Treasurer 32932 PACIFIC COAST HIGHWAY, #14-254, DANA POINT CA 92629
Scott Thomas director 14 MONARCH BEACH PLAZA, SUITE 254, MONARCH BEACH CA 92629
Robert Drust director 14 MONARCH BEACH PLAZA, SUITE 254, MONARCH BEACH CA 92629
Eric Krogius director, 10 percent owner 32932 PACIFIC COAST HIGHWAY, #14-254, DANA POINT CA 92629
Bao Dong Han 10 percent owner 32932 PACIFIC COAST HIGHWAY, #14-254, DANA POINT CA 92629

Agentix (Agentix) Headlines

No Headlines